[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Czech republic authorises ivermectin", "description": "UK, CoViD symptom tracker\n\nhttps://covid.joinzoe.com/data\n\nDrop in news COVID cases resumes \n\nhttps://covid.joinzoe.com/post/drop-in-news-covid-cases-resumes\n\nSymptomatic cases, + 8,111\n\nBased on 9,642 swab tests data from last week\n\nWeek before, + 9,545\n\nDecrease of 15%\n\nDown 88% from a peak of 69,000 at the beginning of the year\n\nPrevalence, 1 in 483 people in the UK currently have symptomatic COVID\n\nhttps://coronavirus.data.gov.uk\n\nCases, + 5,177\nDown 31.3%\n\nDeaths, + 82\nDown 34.8%\n\nHospitalised, + 707\nDown 29.6%\n\nIn patients, 12,876\n\nVaccinations\nFirst dose, 22,213,112\n\nSecond dose, 1,122,402\n\nNicola Sturgeon\n\nEveryone has made so many sacrifices in the past year & seeing a minority risk our progress is infuriating & disgraceful\n\nUK\n\nMinimum of 5 weeks apart\n\nStep One\n\nEngland, From 8 March\n\nAll schools and colleges  open\n\nOutside, with 2 people, tea, picnic\n\nEngland, From 29 March\n\nOutdoor gatherings, six people or two households\n\nIncluding private gardens\n\nOutdoor sports allowed\n\nStep Two\n\nFrom 12 April\n\nPubs and restaurants open for outdoor drinking and eating\n\nNon-essential retail opens, hairdressers and some public buildings like libraries \n\nOutdoor settings like alcohol takeaways, beer gardens, zoos and theme parks\n\nIndoor leisure like swimming pools and gyms\n\nSelf-contained holiday accommodation, and camp sites\n\nStill no indoor mixing between different households\n\nReview of international leisure travel, announced by 12 April at the earliest\n\nFunerals, up to 30 people, weddings up to 15 guests\n\nStep Three\n\nFrom 17 May, at the earliest\n\nIf the data allows\n\nOutdoor, up to 30 people\n\nTwo households can mix indoors\n\nPubs and restaurants, eating inside, rule of six\n\nCinemas, museums, hotels, open\n\nUp to 10,000 spectators outdoor\n\nconsider the potential role of Covid status certification\n\nStep Four\n\nFrom 21 June\n\nPotentially see all legal limits on social contact removed\n\nNightclubs\n\nRestrictions on weddings and funerals will also be abolished\n\nUnited States\n\nCases, 28,771,749\n\nDeaths, 522,973\n\nTrends\n\nhttps://covid.cdc.gov/covid-data-tracker/#trends_dailytrendscases\n\nHospitalizations\n\nhttps://covid.cdc.gov/covid-data-tracker/#hospitalizations\n\nVOCs\n\nhttps://www.cdc.gov/coronavirus/2019-ncov/transmission/variant-cases.html\n\nUS Vaccinations\n\nAdministered, 90,351,750\n\nFirst dose, 58,873,710 (17.7%)\n\nSecond dose, 30,686,881 (9.2%)\n\nDr. Fauci\n\nThose guidelines are coming out from the C.D.C. really imminently\n\nDr. Rochelle Walensky, C.D.C. director\n\nthese are complex issues, and the science is rapidly evolving\n\nWe are making sure and taking the time to get this right\n\nCzech republic\n\nIn order to protect public health\n\nTo ensure the availability of medicinal products important for the provision of health care\n\nhttps://www.mzcr.cz/rozhodnuti-o-docasnem-povoleni-distribuce-vydeje-a-pouzivani-neregistrovaneho-humanniho-leciveho-pripravku-humevec-s-obsahem-lecive-latky-ivermektin/\n\nhttps://www.sukl.eu/medicines/general-guidelines-2\n \nHUVEMEC 3 mg, tablets, manufactured by Huvepharma, Bulgaria, containing the active substance Ivermectin\n\nSubject to a medical prescription\n\nOnly for use in hospitalized patients over 18 years of age\n\nRisk of teratogenicity\n\n0.2 mg / kg / day administered on days 1, 3 and 5\n\nMaximum daily dose of 24 mg was evaluated as safe and most appropriate.\n\nCan be given to inpatient health care providers\n\nDue to the favorable safety profile and lack of other treatment alternatives\n\nIt is more appropriate to allow the use of an unregistered medicinal product under controlled conditions\n\nThus prevent reckless use of Ivermectin obtained on the black market or by using inappropriate veterinary products or dosage forms (cream, paste).\n\nThe patient must be informed that he is being treated with an unregistered medicinal product\n\nthat is not used in accordance with the marketing authorization and will be aware of its benefits and risks.\n\nSlovakia\n\nhttps://www.visegradgroup.eu/news/health-ministry-okays\n\nAuthorises Ivermectin for use against CoViD\n\nIn hospitals and on prescription\n\nFor the next 6 months\n\nAfghanistan\n\nPopulation, 38 million\n\nCases, 55,847\n\nDeaths, 2,449\n\nhttps://www.nytimes.com/live/2021/03/08/world/covid-19-coronavirus#syrias-leader-bashar-al-assad-and-his-wife-have-tested-positive-for-the-virus\n\nCovax initiative, 468,000 AstraZeneca vaccines arrived today\n\nIn addition to 500,000 from India\n\nNew Zealand\n\nBought 10 million Pfizer vaccine doses\n\nOnly vaccine approved so far\n\nMiddle of the year\n\nVietnam\n\nPopulation, 96 million\n\nCases \u2013 2,500\n\nDeaths, 35\n\nBegan immunization program today\n\nOxford-AstraZeneca vaccine\n\nSouth Korea\n\nApprove AstraZeneca today for people 65 +\n\nSyria\n\nPopulation\n\nCases = 17 15,981\n\nDeaths = 1,063\n\nPresident Bashar al-Assad and Asma\n\nTested positive, mild symptoms\n\nQuarantining at home for at least two weeks", "link": "https://www.youtube.com/watch?v=e40EYxdIflk", "date_published": "2021-03-08 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Dr Lawrie, Ivermectin video, Short Precis", "description": "Ivermectin interview, Precis, Dr. Tess Lawrie\n\nVideo 1, the importance of EBP\nSynthesised evidence\n\nVideo 2, Ivermectin\nHeard publicity around Christmas / New Year\n\nFront line covid-19 critical care alliance\n\nhttps://covid19criticalcare.com\n\nDr. Pierre Kory\n\nDr. Lawrie has background expertise required for analysis\n\nWe / I do not prescribe\n\nImpressed with body of evidence from FLCCC\n\nSeveral plausible mechanisms of Ivermectin action, antiviral and anti-inflammatory\n\nPrevents viral life cycles and replication\n\nReduces inflammatory markers\n\nSome studies show Ivermectin reduces viral load\n\nStudies show possible action against yellow fever, dengue, zika and others\n\nLet\u2019s explore with more studies on viral illnesses\n\nPractical empirical evidence\n\nPreventing death and preventing infection\n\nIncluding RCT and better quality observational studies = 83% reduction in deaths\n\nAppraised each study for risk of bias\n\nTalked to authors\n\nReviewed manager software\n\nPooled studies and data\n\nSubmitted to Matt Hancock\u2019s office 4th Jan, no response\n\nPublications coming\n\nResearchers have a moral duty to relay information ASAP, so preprint site (2015)\n\nNext, RCT only\n\nStarting from scratch with a review team, 68% fewer deaths\n\nUsing very strict criteria\n\nForest plot\n\nPlotting deaths in treatment group and deaths in placebo group\n\nOut of 1,000 deaths\nIvermectin group, 27 deaths out of 1,000 cases\nPlacebo group, 82 deaths out of 903 cases\n\n65% reduction\n\nP = 0.002\n\nFindings of RCT was the same as observational studies\n\nUseful in all stages of the disease\n\n88% reductions in infection rates\n\nAnd mild and moderate disease to reduce viral load, so disease worsening\n\n? Long covid\n\nPossible evidence from Argentina and Peru\n\nPlacebo controlled trial for 2 weeks, with options to treat\n\nPlacebo controlled treatment trial, not ethical\n\nReduces symptoms, low certainty, 48%\n\nSafety\n\nBillions of doses have been given over 40 years\n\nWHO, essential medicines list\n\nThird of the world\u2019s population, 4,600 adverse events 16 deaths\n\n(Remdesivir, 417 deaths over past year)\n\nSafe at 10x dose\n\n3, 6, 12 mg tabs\n\n0.2 mg / Kg to 0.4 mg / Kg\n\nOral tabs\n\nCost, $168 per KG\n\nWHO, 100, 12mg tabs $2.90\n\nBIRD, recommended for prevention and treatment in UK, and told everyone, WHO, FDA etc.\n\nHelsinki declaration, doctors should give what they know to be effective\n\nLarge RCT would have to stop at interim analysis, probably at about 1,000 patients\n\nProtection from infection in workers and contacts\n\nIvermectin group, 25 out of 1,397 got covid\n\nControl group, 386 out of 833 got covid\n\nRisk reduction 93% reduction in infection rates\n\nOr 87% with the best study taken out\n\nMedical oil tankers\n\nIvermectin reduces the risk of death from COVID-19 -a rapid review and meta-analysis in support of the recommendation of the Front Line COVID-19 Critical Care Alliance.\n\nhttps://www.researchgate.net/publication/348297284_Ivermectin_reduces_the_risk_of_death_from_COVID-19_-a_rapid_review_and_meta-analysis_in_support_of_the_recommendation_of_the_Front_Line_COVID-19_Critical_Care_Alliance_Latest_version_v12_-_6_Jan_2021\n\nKory P, Meduri GU, Iglesias J, et al. Review of the emerging evidence demonstrating the efficacy of ivermectin in the prophylaxis and treatment of COVID-19. 18 Dec 2020.\nhttps://covid19criticalcare.com/wp-content/uploads/2020/11/FLCCC-Ivermectin-in-the-prophylaxis-and-treatment-of-COVID-19.pdf\n\nWorld Health Organization. 21st Model List of Essential Medicines. Geneva, Switzerland. 2019.\nhttps://www.who.int/publications/i/item/WHOMVPEMPIAU2019.06\n\nHiggins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 6.0 Cochrane, 2019.\nwww.training.cochrane.org/handbook. \n\nThe GRADE Working Group. GRADE [website] 2020\n www.gradeworkinggroup.org. \n\nAlam MT, Murshed R, Gomes PF, Masud ZM, Saber S, Chaklader MA, Khanam F, Hossain M, Momen ABIM, Yasmin N, Alam RF, Sultana A, Robin RC. Ivermectin as Pre-exposure Prophylaxis for COVID-19 among Healthcare Providers in a Selected Tertiary Hospital in Dhaka \u2013 An Observational Study", "link": "https://www.youtube.com/watch?v=ix8i7dfsCJg", "date_published": "2021-03-07 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]